Literature DB >> 7848520

Bcl-2 and Bcl-x: regulatory switches for lymphoid death and survival.

G Núñez1, R Merino, D Grillot, M González-García.   

Abstract

The survival and death of lymphoid cells is under the control of a genetic program. Cell death is activated at different stages of development and serves to remove unnecessary and autoreactive lymphocytes, as well as to limit the immune response. The survival of cells is regulated by a set of genes that act as repressors of the cell death mechanism. Of these, bcl-2 and bcl-x exhibit a striking pattern of regulation during lymphoid maturation and can inhibit several forms of apoptotic cell death. Here, Gabriel Núñez and colleagues review recent developments in the field, particularly focusing on the role of the Bcl-2 and Bcl-x proteins in regulating lymphoid death and survival.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7848520     DOI: 10.1016/0167-5699(94)90221-6

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


  26 in total

Review 1.  Apoptosis: molecular mechanisms and implications for cancer chemotherapy.

Authors:  H J Guchelaar; A Vermes; I Vermes; C Haanen
Journal:  Pharm World Sci       Date:  1997-06

2.  Programmed cell death (apoptosis) in cord blood lymphocytes.

Authors:  S Aggarwal; A Gupta; S Nagata; S Gupta
Journal:  J Clin Immunol       Date:  1997-01       Impact factor: 8.317

Review 3.  Apoptosis in B-chronic lymphocytic leukaemia.

Authors:  L M Osorio; M Aguilar-Santelises
Journal:  Med Oncol       Date:  1998-12       Impact factor: 3.064

4.  An essential role for Bruton's [corrected] tyrosine kinase in the regulation of B-cell apoptosis.

Authors:  J S Anderson; M Teutsch; Z Dong; H H Wortis
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

5.  Actinobacillus actinomycetemcomitans toxin induces both cell cycle arrest in the G2/M phase and apoptosis.

Authors:  M Ohguchi; A Ishisaki; N Okahashi; M Koide; T Koseki; K Yamato; T Noguchi; T Nishihara
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

6.  Apurinic/apyrimidinic endonuclease 2 is necessary for normal B cell development and recovery of lymphoid progenitors after chemotherapeutic challenge.

Authors:  Jeroen E J Guikema; Rachel M Gerstein; Erin K Linehan; Erin K Cloherty; Eric Evan-Browning; Daisuke Tsuchimoto; Yusaku Nakabeppu; Carol E Schrader
Journal:  J Immunol       Date:  2011-01-12       Impact factor: 5.422

7.  A novel Bcl-x isoform connected to the T cell receptor regulates apoptosis in T cells.

Authors:  X F Yang; G F Weber; H Cantor
Journal:  Immunity       Date:  1997-11       Impact factor: 31.745

Review 8.  Superantigens in insulin-dependent diabetes mellitus.

Authors:  P Luppi; M Trucco
Journal:  Springer Semin Immunopathol       Date:  1996

9.  Kaposi's sarcoma tumor cells preferentially express Bcl-xL.

Authors:  K E Foreman; T Wrone-Smith; L H Boise; C B Thompson; P J Polverini; P L Simonian; G Nunez; B J Nickoloff
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

10.  Role of passive T-cell death in chronic experimental autoimmune encephalomyelitis.

Authors:  S Issazadeh; K Abdallah; T Chitnis; A Chandraker; A D Wells; L A Turka; M H Sayegh; S J Khoury
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.